Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer biotech ...
Abstract: Recently, foundation models (such as ChatGPT) have emerged with powerful learning, understanding, and generalization abilities, showcasing tremendous potential to revolutionarily promote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results